ASH Impact Series: Jennifer Woyach, MD – The Latest CLL Research in Relation to New Drug Therapies



Jennifer Woyach, MD, discusses the latest drug treatments for CLL patients. Dr. Woyach presented on the topic at the 2015 ASH Annual Meeting in a session titled "New Approaches in Chronic Lymphocytic Leukemia and Prolymphocytic Leukemia."


  • Jennifer Woyach, MD

back to top